Related Experiment Videos
Lack of efficacy of single-dose prednisolone in moderately severe asthma
L Ho1, L I Landau, P N Le Souëf
1Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, WA.
Insights
Single-dose prednisolone did not improve recovery or shorten hospital stays for children with severe asthma attacks. This study found no significant benefit in managing acute severe asthma in pediatric patients.
Area of Science:
- Pediatric Pulmonology
- Clinical Pharmacology
- Emergency Medicine
Background:
- Acute severe asthma is a common pediatric emergency.
- Corticosteroids are a mainstay in asthma management.
- The optimal corticosteroid regimen for acute severe asthma in children requires further investigation.
Purpose of the Study:
- To evaluate the efficacy of a single dose of prednisolone in pediatric patients with moderately severe asthma.
- To determine if a single-dose prednisolone regimen reduces illness duration and hospital stay.
- To assess the impact of single-dose prednisolone on oxygen saturation and lung function recovery.
Main Methods:
- A randomized, double-blind, controlled trial was conducted.
- 64 children admitted with acute asthma and oxygen saturation <93% were enrolled.
- Participants received either a single dose of prednisolone or a placebo.
Main Results:
- No statistically significant differences were observed in the rate of oxygen saturation recovery between groups.
- Lung function measurements showed no significant improvement with single-dose prednisolone.
- The duration of hospital stay was not significantly reduced by the intervention.
Conclusions:
- A single dose of prednisolone did not demonstrate a significant benefit in the management of acute severe asthma in children.
- The findings do not support the use of a single-dose prednisolone regimen for this patient population.
- Further research may be needed to explore alternative or optimized corticosteroid treatment strategies.
Objective:
To assess the effectiveness of single-dose prednisolone in reducing the length of illness and hospital stay in children admitted with moderately severe asthma.
Design:
A randomised, double-blind, controlled trial of a single dose of prednisolone in 64 children presenting with an acute attack of asthma with arterial oxygen saturation less than 93%.
Results:
No significant differences in the rate of recovery of oxygen saturation, lung function measurements or duration of hospital stay were found.
Conclusions:
This study failed to confirm the benefit of a single dose of prednisolone in the management of children with acute severe asthma.